.png){kind=icon}
.png){kind=icon}
Return
Real-World Experience With Control-IQ Technology in Saudi Children With Insulin-Dependent Diabetes: A Single-Center Observational Study
.png){kind=icon}
OA
AI
A
B
R
R
A
N
S
DOI：10.1155/pedi/6113065.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
The Tandem t:slim X2 insulin pump with the Control-IQ technology (Control-IQ) is an automated insulin delivery (AID) system for glycemic control but has limited data in Saudi pediatric and young adult populations. We aim to evaluate the efficacy and safety of Control-IQ therapy in children with insulin-dependent diabetes and previously treated with multiple daily injections (MDIs). The primary outcome is to assess the change in HbA1c 6 months after initiating Control-IQ technology.
Keywords:
glycemic control
insulin pump
insulin-dependent diabetes
pediatrics
Saudi Arabia
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
5.6
Papers:
2.3K
Citations:
5.4K
Organization
Cited Papers